Skip to Main Content

Author Details

Siyuan Zheng
Greehey Children's Cancer Research Institute
2007
90
35
PMIDPaper TitleJournal TitlePublished Year
36622331Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow-Derived Macrophages.Cancer Res2023
37556038An Increase in Peroxiredoxin 6 Expression Induces Neurotoxic A1 Astrocytes in the Lumbar Spinal Cord of Amyotrophic Lateral Sclerosis Mice Model.Neurochem Res2023
36652263Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma.Neuro Oncol2023
36622331Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow-Derived Macrophages.Cancer Res2023
37434235PHF5A regulates the expression of the DOCK5 variant to promote HNSCC progression through p38 MAPK activation.Biol Direct2023
37359725DepLink: an R Shiny app to systematically link genetic and pharmacologic dependencies of cancer.Bioinform Adv2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
37556038An Increase in Peroxiredoxin 6 Expression Induces Neurotoxic A1 Astrocytes in the Lumbar Spinal Cord of Amyotrophic Lateral Sclerosis Mice Model.Neurochem Res2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
37434235PHF5A regulates the expression of the DOCK5 variant to promote HNSCC progression through p38 MAPK activation.Biol Direct2023
37359725DepLink: an R Shiny app to systematically link genetic and pharmacologic dependencies of cancer.Bioinform Adv2023
36652263Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma.Neuro Oncol2023
35303054M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression.Cancer Res2022
35450020Approaches to identifying drug resistance mechanisms to clinically relevant treatments in childhood rhabdomyosarcoma.Cancer Drug Resist2022
36358818Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth.Cancers (Basel)2022
36122307Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma.Cancer Discov2022
36433963Genomic disparities between cancers in adolescent and young adults and in older adults.Nat Commun2022
36595948Protocol to benchmark gene expression signature scoring techniques for single-cell RNA sequencing data in cancer.STAR Protoc2022
35212622Signature-scoring methods developed for bulk samples are not adequate for cancer single-cell RNA sequencing data.Elife2022
35303054M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression.Cancer Res2022
35223867Multi-Omics Characterization of Tumor Microenvironment Heterogeneity and Immunotherapy Resistance Through Cell States-Based Subtyping in Bladder Cancer.Front Cell Dev Biol2022
35450020Approaches to identifying drug resistance mechanisms to clinically relevant treatments in childhood rhabdomyosarcoma.Cancer Drug Resist2022
36433963Genomic disparities between cancers in adolescent and young adults and in older adults.Nat Commun2022
36595948Protocol to benchmark gene expression signature scoring techniques for single-cell RNA sequencing data in cancer.STAR Protoc2022
36358818Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth.Cancers (Basel)2022
36122307Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma.Cancer Discov2022
35223867Multi-Omics Characterization of Tumor Microenvironment Heterogeneity and Immunotherapy Resistance Through Cell States-Based Subtyping in Bladder Cancer.Front Cell Dev Biol2022
35212622Signature-scoring methods developed for bulk samples are not adequate for cancer single-cell RNA sequencing data.Elife2022
32810235PCAT: an integrated portal for genomic and preclinical testing data of pediatric cancer patient-derived xenograft models.Nucleic Acids Res2021
33592124Hepatitis C Virus RNA Transcript Associates with Prognosis in Non-human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma.Laryngoscope2021
33968684A characterization and prognosis prediction model for primary squamous cell carcinoma of the thyroid.Gland Surg2021
34321211Regulation of telomere homeostasis and genomic stability in cancer by <i>N</i> <sup>6</sup>-adenosine methylation (m<sup>6</sup>A).Sci Adv2021
32810235PCAT: an integrated portal for genomic and preclinical testing data of pediatric cancer patient-derived xenograft models.Nucleic Acids Res2021
33420056Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation.Nat Commun2021
33434495A modular master regulator landscape controls cancer transcriptional identity.Cell2021
34462275SNAI2-Mediated Repression of <i>BIM</i> Protects Rhabdomyosarcoma from Ionizing Radiation.Cancer Res2021
34417181Predicting and characterizing a cancer dependency map of tumors with deep learning.Sci Adv2021
33592124Hepatitis C Virus RNA Transcript Associates with Prognosis in Non-human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma.Laryngoscope2021
34462275SNAI2-Mediated Repression of <i>BIM</i> Protects Rhabdomyosarcoma from Ionizing Radiation.Cancer Res2021
34417181Predicting and characterizing a cancer dependency map of tumors with deep learning.Sci Adv2021
33968684A characterization and prognosis prediction model for primary squamous cell carcinoma of the thyroid.Gland Surg2021
34321211Regulation of telomere homeostasis and genomic stability in cancer by <i>N</i> <sup>6</sup>-adenosine methylation (m<sup>6</sup>A).Sci Adv2021
33434495A modular master regulator landscape controls cancer transcriptional identity.Cell2021
33420056Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation.Nat Commun2021
32699356Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.Nat Commun2020
31852834<i>EGFR</i> Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma.Clin Cancer Res2020
32101699MYC Regulation of D2HGDH and L2HGDH Influences the Epigenome and Epitranscriptome.Cell Chem Biol2020
31927611Prospective use of the single-mouse experimental design for the evaluation of PLX038A.Cancer Chemother Pharmacol2020
31813953Deep learning of pharmacogenomics resources: moving towards precision oncology.Brief Bioinform2020
32699356Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.Nat Commun2020
  • 1 - 50 of 180

Recommended Authors

Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
Career Start Year 2016
Number of shared co-authors 14
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 4
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 6
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2010
Number of shared co-authors 30
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 12
Broad Institute of Harvard and MIT
Career Start Year 2010
Number of shared co-authors 4
University of Science and Technology Liaoning
Career Start Year 2009
Number of shared co-authors 5
Princess Maxima Center for Pediatric Oncology
Career Start Year 2008
Number of shared co-authors 2
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 4
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 15
St. Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 15
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 8
Novartis Institutes for BioMedical Research
Career Start Year 2005
Number of shared co-authors 5
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 12
University of Augsburg
Career Start Year 2004
Number of shared co-authors 26
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 16
Washington University
Career Start Year 2003
Number of shared co-authors 24
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Washington University
Career Start Year 2003
Number of shared co-authors 21
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 30
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 11
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 14
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 18
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 26
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 85
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 19
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 8
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 44
University of California San Diego
Career Start Year 1988
Number of shared co-authors 42
University of California los angeles
Career Start Year 1970
Number of shared co-authors 45

Collaborators

Yale School of Medicine
Co-authored papers 32
University of Texas M.D. Anderson Cancer Center
Co-authored papers 13
The University of Texas Health Science Center at San Antonio
Co-authored papers 10
Center for Precision Health, The University of Texas Health Science Center at Houston
Co-authored papers 10
The University of Texas MD Anderson Cancer Center
Co-authored papers 9
Center for Global Health, School of Public Health, Nanjing Medical University
Co-authored papers 9
NYU Grossman School of Medicine
Co-authored papers 9
The University of Texas Health Science Center at San Antonio
Co-authored papers 8
Ontario Brain Institute
Co-authored papers 7
Co-authored papers 7
Broad Institute
Co-authored papers 6
Dana-Farber Cancer Institute
Co-authored papers 6
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Van Andel Institute
Co-authored papers 6
Present address: Dxige Research Inc.
Co-authored papers 5
Baylor College of Medicine
Co-authored papers 5
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Greehey Children's Cancer Research Institute
Co-authored papers 5
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 5
National Cancer Institute
Co-authored papers 5
Co-authored papers 5
National Cancer Institute
Co-authored papers 5
IRCCS San Raffaele Scientific Institute
Co-authored papers 4
University of California Santa Cruz Genomics Institute
Co-authored papers 4
Genomics Institute, University of California Santa Cruz
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 4
Broad Institute of MIT and Harvard
Co-authored papers 4
University of Lausanne (UNIL)
Co-authored papers 4